LNTH Q4 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$86M+6.2% YoY

Gross Profit

$44M50.8% margin

Operating Income

$17M19.6% margin

Net Income

$13M15.4% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

-3.0%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$440M

Total Liabilities

$369M

Stockholders' Equity

$71M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$81M	+6.2%
Gross Profit	$44M	$38M	+15.7%
Operating Income	$17M	$9M	+84.0%
Net Income	$13M	$97M	-86.3%

Revenue Segments

US Segment

$73M84%

International Segment

$14M16%